In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.
The study, led by TSRI Associate Professor Susana Valente, was published online Oct. 17 before print in the journal Cell Reports.
“No other anti-retroviral used in the clinic today is able to completely suppress viral production in infected cells in vivo,” Valente said. “When combining this drug with the standard cocktail of anti-retrovirals used to suppress infection in humanized mouse models of HIV-1 infection, our study found a drastic reduction in virus RNA present—it is really the proof-of-concept for a ‘functional cure.’”
Valente, a pioneer in this new approach, calls it “Block-and-Lock”—the approach blocks reactivation of the virus in cells, even during treatment interruptions, and locks HIV into durable state of latency.
Valente and her colleagues use a derivative of a natural compound called didehydro-Cortistatin A (dCA), which blocks replication in HIV-infected cells by inhibiting the viral transcriptional activator, called Tat, halting viral production, reactivation and replenishment of the latent viral reservoir.
“Combining dCA with anti-retroviral therapy accelerates HIV-1 suppression and prevents viral rebound after treatment interruption, even during strong cellular activation,” Valente said. “It’s important to note that our study uses the maximum tolerable dose of the drug—with virtually no side effects.”
The scientists studied the combination therapy in a mouse model of HIV latency and persistence. Once the combined treatment regimen was halted, viral rebound was delayed up to 19 days, compared with just seven days in mouse models receiving only anti-retroviral treatment.
“This demonstrates the potential of ‘block-and-lock’ strategies,” said TSRI Research Associate Cari F. Kessing, co-first author of the study. “This study shows that a ‘functional cure’ approach can succeed in reducing residual virus in the blood during anti-retroviral treatment and limiting viral rebound during treatment interruption.”
“In half of the dCA treated mice, the virus was undetectable for 16 days after all treatment was halted,” said the University of North Carolina’s Christopher Nixon, another first author.
“We blocked Tat, and the cell’s machinery did the rest,” said TSRI Research Associate Chuan Li, a coauthor of the study. “The result was that the HIV promoter becomes repressed.”
Valente pointed out that the animal models were exposed to just a single month of treatment. “That’s a relatively short period of time,” she said. “We think longer treatments will result in longer, or even permanent, rebound delays. The question is how long? We’re studying that now.”
Because any viral rebound of HIV comes with a host of adverse effects, Valente noted, blocking that rebound would automatically reduce those effects.
“This is the only class of drugs that stops infected cells from making viruses outright,” said Valente. “All current antivirals work later in the viral lifecycle, so only a HIV transcriptional inhibitor like dCA can stop the side effects of low-level virus production.”
The Latest on: HIV
- HIV and Hispanic/Latino Gay and Bisexual Menon October 16, 2021 at 11:09 am
Hispanic/Latino a gay, bisexual, and other men who reported male-to-male sexual contact b,c are disproportionately affected by HIV. Social and structural issues—such as racism, HIV stigma, homophobia, ...
- Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.on October 16, 2021 at 10:32 am
Many people who remain persistently seronegative despite frequent HIV exposure have HIV-specific immune responses. The study of these may provide information about mechanisms of natural protective ...
- JVN Shuts Down ‘Dumb’ Marjorie Taylor Greene Over HIV Tweetson October 16, 2021 at 8:34 am
"The fascist NBA won't let Kyrie Irving play for refusing a vaccine," Georgia Republican, Congresswoman Marjorie Taylor Green tweeted Thursday. She was referring to an ongoing NBA dispute where the ...
- In observance of Latinos AIDS Awareness Day, Phoenix organization offers free HIV testingon October 16, 2021 at 8:26 am
The organization Sonoran Prevention Works will host an event Saturday to offer free HIV and Hepatitis C testing for the Latino community in Arizona ...
- 'Elite neutralizing' antibody demonstrates long-term viral suppression in persons living with HIV in phase 1 trialon October 16, 2021 at 7:40 am
BIDMC physicians-scientists led a phase 1 clinical trial finding that antibody PGT121 demonstrated antiviral activity in adults living with HIV. Read more.
- Bringing it all together: big data and HIV researchon October 16, 2021 at 5:54 am
Several groups have started to develop data repositories and computational tools for HIV research, providing important starting points. The National Center for Biotechnology Information (NCBI) hosts ...
- HIV and Hispanic/Latino Gay and Bisexual Men: Viral Suppressionon October 15, 2021 at 2:40 pm
It is important for Hispanic/Latino gay and bisexual men to know their HIV status so they can take medicine to treat HIV if they have the virus. Taking HIV medicine every day can make the viral load ...
- Conservatives are comparing unvaccinated Kyrie Irving to Magic Johnson and HIV. Critics say that’s rooted in myth.on October 15, 2021 at 1:36 pm
The Brooklyn Nets point guard not wanting to get a coronavirus vaccination is not at all similar to what the Lakers great did after announcing he had contracted HIV in 1991, say players, coaches and ...
- Marjorie Taylor Greene called the NBA 'fascist' for allowing Magic Johnson to 'play with HIV' while Kyrie Irving stays benchedon October 14, 2021 at 8:24 pm
Greene was protesting the benching of Brooklyn Nets player Kyrie Irving, who will be kept off the court until he gets the COVID-19 vaccine.
- This Spanish-Language Ad Stars a Real-Life HIV Heroon October 14, 2021 at 6:24 pm
The scenario that plays out in a recent ad for the HIV medication Dovato is much like a typical day for Luciano Reberte, who stars in the Spanish-language commercial — the first of its kind for the ...
via Google News and Bing News